Unibest
← Back to patent-cliff list

CAS 141-97-9

ethyl 3-oxobutanoate1-Ethoxybutane-1,3-dioneAcetoacetic ethyl esterEthyl 3-oxobutanoate

Codes: PALB-027, (XXXVI)1024528-1-d, Ceftazidime-001, Lercanidipine Hydrochloride-045, SITAF-014, SUNT-012, Cilastatin Sodium-023

Application context (from source-drug indications)

Breast cancerPalbociclibNon-small cell lung cancerPralsetinibThyroid cancerPralsetinibMedullary thyroid cancerPralsetinibCystitisAvibactam Sodium/CeftazidimeCholecystitisAvibactam Sodium/CeftazidimePeritonitisAvibactam Sodium/CeftazidimeIntra-abdominal infectionAvibactam Sodium/CeftazidimeLiver abscessAvibactam Sodium/CeftazidimeSepsisAvibactam Sodium/CeftazidimeEssential hypertensionValsartan/Lercanidipine HydrochlorideBacterial infectionCeftazidime/Tazobactam SodiumRespiratory tract infectionCeftazidime/Tazobactam SodiumUrinary tract infectionCeftazidime/Tazobactam SodiumCystitisSitafloxacin HydrateSinusitisSitafloxacin HydrateTonsillitisSitafloxacin HydratePneumoniaSitafloxacin HydrateCervicitisSitafloxacin HydratePericoronitisSitafloxacin HydratePancreatic neuroendocrine tumourSunitinib MalateRenal cell carcinomaSunitinib MalateGastrointestinal stromal tumourSunitinib MalateOsteosarcomaSunitinib MalateSarcomaSunitinib MalateLymphomaSunitinib MalateBacterial infectionCeftazidimeGram-positive bacterial infectionCeftazidimeGram-negative bacterial infectionCeftazidimeGynaecological disorderCeftazidimeIntra-abdominal infectionCeftazidimeOsteoarthritisCeftazidimeHypertensionLercanidipine HydrochlorideInfectious diseaseCilastatin Sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
PalbociclibTier A — Act now2027
PralsetinibTier C — Watch / trade2031
Avibactam Sodium/CeftazidimeTier C — Watch / trade-
Valsartan/Lercanidipine HydrochlorideTier C — Watch / trade-
Ceftazidime/Tazobactam SodiumTier C — Watch / trade-
Sitafloxacin HydrateTier C — Watch / trade-
Sunitinib MalateTier B — Position early-
CeftazidimeTier C — Watch / trade-
Lercanidipine HydrochlorideTier C — Watch / trade-
Cilastatin SodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

PralsetinibOptimised routesteps: 6total yield: /
Cilastatin SodiumOptimised routesteps: 1total yield: 18.6g(Cilastatin Sodium-024)

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Workstert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteTert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Sitetert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksPD 0332991 HCl
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteCarbamic acid, (7S)-5-azaspiro[2.4]hept-7-yl-, 1,1-dimethylethyl ester (9CI)
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-Fluoro-2-oxindole
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.